Healthcare - Biotechnology - NASDAQ - NL
$ 46.58
-6.2 %
$ 3.19 B
Market Cap
-11.56
P/E
Price Target
Average
73.31%
Revenue Forecast
Estimate
80.24%
EBIT
Estimate
--31.20%
Net Income
Estimate
10.45%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Merus N.V.
Wall Street analysts predict an average 1-year price target for MRUS of $80.7 , with forecasts ranging from a low of $58 to a high of $99 .
MRUS Lowest Price Target
Wall Street Target
58 USD
24.52%
MRUS Average Price Target
Wall Street Target
80.7 USD
73.31%
MRUS Highest Price Target
Wall Street Target
99 USD
112.54%
REVENUE FORECAST
Revenue Forecast Chart MRUS
EBIT FORECAST
EBIT Forecast Chart MRUS
NET INCOME FORECAST
Net Income Chart MRUS